Cardurion logo - click to return to the homepage

Cardurion Pharmaceuticals Bolsters Leadership Team with Appointment of Elizabeth Radcliffe as Chief Financial Officer

Strategic Finance Leader Brings Deep Biopharmaceutical Industry Experience and Track Record of Successful Leadership BURLINGTON, Mass.–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (“Cardurion” or “the Company”), a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of cardiovascular diseases, today announced the appointment of Elizabeth Radcliffe as Chief Financial Officer. A […]

This site uses cookies and third-party scripts to provide certain services. View Privacy Policy

Skip to content